Back

Q&A.

28 August 2021 (11:20 - 12:00)
Organised by:
Congress Presentation Part of: Atrial fibrillation screening and biomarkers to assess stroke and bleeding risks in atrial fibrillation patients Arrhythmias, General Open Access ESC Congress 2021 - The Digital Experience

2 More presentations in this session

Presentation thumbnail
NT-proBNP: a valuable marker to screen for Atrial Fibrillation.
Doctor K. Kemp Gudmundsdottir (Reykjavik, IS)
Presentation thumbnail
The value of biomarkers to assess stroke and bleeding risks in atrial fibrillation patients.
Associate Professor Z. Hijazi (Uppsala, SE)

Access the full session

Session thumbnail
Atrial fibrillation screening and biomarkers to assess stroke and bleeding risks in atrial fibrillation patients
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 11:20 CET
You may be interested in
thumbnail
Congress Presentation
EAS Consensus on Lp(a) 2022- What to measure, in whom to measure, how to interpret and what to do - Q&A .
29 August 2022
thumbnail
Congress Presentation
Summary.
29 August 2022
thumbnail
Congress Presentation
Discussion.
27 August 2022
thumbnail
Congress Presentation
The patient behind the fourth drug question
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources